上海雪榕生物科技股份有限公司 2025 年半年度报告全文 上海雪榕生物科技股份有限公司 2025 年半年度报告 2025-080 2025 年 8 月 1 上海雪榕生物科技股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人杨勇萍、主管会计工作负责人杨勇萍及会计机构负责人(会计 主管人员)陈笑笑声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本半年度报告如有涉及未来计划等前瞻性陈述，均不构成公司对投资者的 实质承诺，投资者及相关人士均应当对此保持足够的风险认识，并且应当理 解计划、预测与承诺之间的差异，敬请投资者注意投资风险，理性投资。 公司需遵守《深圳证券交易所上市公司自律监管指引第 3 号——行业信 息披露》中的"种业、种植业务"的披露要求 公司存在"市场竞争加剧导致产品价格下降的风险"、"原材料价格波动 风险"、"资金风险"、"毛利率下降的风险及利润下降的风险"等风险 ...

本公司及出席本次董事会的董事会全体成员保证信息披露内容的真实、准确 和完整，没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 | 证券代码：300511 | 证券简称：雪榕生物 | 公告编号：2025-075 | | --- | --- | --- | | 债券代码：123056 | 债券简称：雪榕转债 | | 上海雪榕生物科技股份有限公司 第五届董事会第三十一次会议决议公告 1、本次董事会由董事长杨勇萍先生召集，会议通知于 2025 年 8 月 16 日以 电子邮件等通讯方式发出。 2、本次董事会于 2025 年 8 月 26 日在上海雪榕生物科技股份有限公司（以 下简称"公司"）会议室召开，采取现场和通讯相结合的方式进行表决。 3、本次会议应出席董事 7 人，实际出席董事 7 人。 4、本次董事会由董事长杨勇萍先生主持，公司监事、高级管理人员列席了 本次董事会。 5、本次董事会会议的召集、召开和表决程序符合《公司法》等法律、法规 及《公司章程》的有关规定，合法有效。 二、董事会会议审议情况 1、审议通过《关于 2025 年半年度报告及其摘要的议案》 经审议，董事会认为：公司《2025年半年度报 ...

Core Insights - The planting industry sector experienced a slight increase of 0.29% on August 26, with Kangnong Seed leading the gains [1] - The Shanghai Composite Index closed at 3868.38, down 0.39%, while the Shenzhen Component Index closed at 12473.17, up 0.26% [1] Sector Performance - Kangnong Seed (837403) closed at 26.93, up 3.02% with a trading volume of 62,200 shares and a transaction value of 167 million yuan [1] - Other notable performers included: - Bowan Technology (600883) at 8.51, up 1.79% [1] - Dunhuang Seed (600354) at 6.84, up 1.79% [1] - Jinhai Seed (002041) at 10.15, up 0.89% [1] - Zhongxing Fungi (002772) at 8.32, up 0.85% [1] Capital Flow - The planting industry sector saw a net outflow of 275 million yuan from major funds, while retail investors contributed a net inflow of 253 million yuan [2] - The following companies had significant capital flows: - Dunhuang Seed (600354) had a net inflow of 15.99 million yuan from major funds [3] - Bowan Technology (600883) saw a net inflow of 6.47 million yuan from major funds [3] - Zhongxing Fungi (002772) experienced a net inflow of 4.66 million yuan from major funds [3]

Group 1 - The article discusses the transformation of traditional snack brands in Fujian, China, as they adapt to the challenges posed by e-commerce and changing consumer preferences [3][5][6] - It highlights the shift from traditional distribution channels to online platforms, particularly the role of Pinduoduo in enabling these brands to reach new consumer segments [10][14][19] - The article emphasizes the importance of data-driven decision-making in product development, allowing brands to quickly respond to consumer preferences and market trends [10][11][18] Group 2 - The case studies of brands like La Pi Xiu and You Chen illustrate how these companies have successfully leveraged Pinduoduo's support policies, such as "hundred billion subsidies" and "thousand billion support," to enhance their market presence [11][14][18] - The article notes that the collaboration with Pinduoduo has allowed these brands to reduce operational costs and improve their product offerings, leading to significant sales growth [11][19] - It concludes that the combination of established brand heritage and new e-commerce strategies is crucial for the revival and growth of these traditional snack brands in a competitive market [19]

Market Overview - The planting industry sector increased by 0.95% on August 20, with Xue Rong Biological leading the gains [1] - The Shanghai Composite Index closed at 3766.21, up 1.04%, while the Shenzhen Component Index closed at 11926.74, up 0.89% [1] Stock Performance - Key stocks in the planting industry and their performance include: - Xue Rong Biological (300511): Closed at 6.92, up 5.65% with a trading volume of 568,400 shares and a turnover of 387 million yuan [1] - Wanxiang Deno (600371): Closed at 9.85, up 5.01% with a trading volume of 329,000 shares and a turnover of 322 million yuan [1] - Honglian Zhaoshu (603336): Closed at 9.30, up 1.42% with a trading volume of 140,860 shares and a turnover of 38 million yuan [1] - Hainan Rubber (601118): Closed at 5.17, up 1.37% with a trading volume of 544,800 shares and a turnover of 280 million yuan [1] Capital Flow - The planting industry sector saw a net inflow of 139 million yuan from main funds, while retail investors experienced a net outflow of 139 million yuan [1] - Detailed capital flow for selected stocks includes: - Xue Rong Biological: Main funds net inflow of 50.77 million yuan, retail net outflow of 62.57 million yuan [2] - Wanxiang Deno: Main funds net inflow of 30.02 million yuan, retail net outflow of 13.87 million yuan [2] - Fengle Seed Industry (000713): Main funds net inflow of 14.37 million yuan, retail net outflow of 6.88 million yuan [2]

Market Overview - The planting industry sector experienced a decline of 1.48% on August 14, with Xue Rong Biological leading the drop [1] - The Shanghai Composite Index closed at 3666.44, down 0.46%, while the Shenzhen Component Index closed at 11451.43, down 0.87% [1] Stock Performance - Notable stock performances in the planting industry include: - Hainan Rubber (601118) closed at 4.94 with no change - Su Kan Agricultural Development (601952) closed at 9.62, down 0.82% - Honghui Fruits and Vegetables (603336) closed at 8.00, down 0.87% - Fengle Seed Industry (000713) closed at 7.12, down 0.97% - Jiangping High-Tech (000998) closed at 9.90, down 1.00% - Beidahuang (600598) closed at 14.86, down 1.20% [1] Capital Flow - The planting industry sector saw a net outflow of 364 million yuan from main funds, while speculative funds had a net inflow of 103 million yuan, and retail investors saw a net inflow of 262 million yuan [2] - Detailed capital flow for specific stocks includes: - Honghui Fruits and Vegetables (603336) had a main fund net inflow of 21.19 million yuan - Hainan Rubber (601118) had a main fund net inflow of 10.07 million yuan - Hua Green Biological (300970) experienced a main fund net outflow of 0.98 million yuan [3]

Group 1 - The planting industry sector experienced a decline of 0.67% on August 12, with Kangnong Seed Industry leading the drop [1] - The Shanghai Composite Index closed at 3665.92, up 0.5%, while the Shenzhen Component Index closed at 11351.63, up 0.53% [1] - Major stocks in the planting industry showed mixed performance, with some stocks like Xue Rong Biological and Hong Lian Fruits and Vegetables increasing by 0.74% [1] Group 2 - Kangnong Seed Industry's stock price fell by 2.93% to 24.85, with a trading volume of 31,200 shares and a transaction value of 78.28 million yuan [2] - The planting industry sector saw a net outflow of 324 million yuan from main funds, while retail investors contributed a net inflow of 211 million yuan [2] - Notable declines included Dunhuang Seed Industry down 2.30% and Shennong Seed Industry down 1.61% [2]

上海雪榕生物科技股份有限公司 详式权益变动报告书 （修订稿） 上市公司名称：上海雪榕生物科技股份有限公司 信息披露义务人：上海万紫千鸿智能科技有限公司 住所：上海市宝山区月罗路559号 通讯地址：上海市徐汇区龙爱路7号芒果广场B栋1101 股份变动性质：股份增加 签署日期：2025年8月 股票上市地点：深圳证券交易所 股票简称：雪榕生物 股票代码：300511 债券简称：雪榕转债 债券代码：123056 上海雪榕生物科技股份有限公司 详式权益变动报告书 修订说明 信息披露义务人已于2025年3月13日公告了《上海雪榕生物科技股份有限公 司详式权益变动报告书》，现基于本次权益变动涉及的相关事项发生变化，信 息披露义务人对本次权益变动相关情况进行补充说明及修订，主要修订内容如 下： 一、根据信息披露义务人上层股东上海佰玥智能科技有限公司更名为上海 佰玥智能科技集团有限公司，更新了信息披露义务人股权结构中该股东的名称。 更新信息披露义务人通讯地址。 详见本报告书之"第二节 信息披露义务人介绍"。 二、根据信息披露义务人于2025年3月31日签署的《股份转让协议之补充协 议（一）》，于2025年4月16日签署的《控制 ...

北京博星证券投资顾问有限公司 关于上海雪榕生物科技股份有限公司 详式权益变动报告书 之 财务顾问核查意见 （修订稿） 财务顾问 二〇二五年八月 | 第一节 | 释义 4 | | --- | --- | | 第二节 | 序言 6 | | 第三节 | 财务顾问承诺与声明 7 | | | 一、财务顾问承诺 7 | | | 二、财务顾问声明 7 | | 第四节 | 财务顾问意见 9 | | | 一、对详式权益变动报告书内容的核查 9 | | | 二、对权益变动目的的核查 9 | | | 三、对信息披露义务人基本情况的核查 9 | | | 四、对信息披露义务人进行证券市场规范化运作辅导的情况 13 | | | 五、对本次权益变动的方式的核查 13 | | | 六、对本次权益变动所涉及股份的权利限制情况的核查 16 | | | 七、对未来 个月内继续增持或者处置已拥有权益股份的计划的核查 16 12 | | | 八、对本次权益变动资金来源及合法性的核查 16 | | | 九、对本次权益变动所履行的决策程序的核查 17 | | | 十、对信息披露义务人后续计划的核查 17 | | | 十一、对过渡期间保持上市公司稳定经营的 ...

Group 1 - The core point of the news is that Shanghai Xuerong Biotechnology Co., Ltd. plans to establish a new subsidiary, Chengdu Xuesao Biotechnology Co., Ltd., to focus on the artificial cultivation and commercialization of Cordyceps, a species of national secondary protected plant [1] - Chengdu Xuesao will have a registered capital of 20 million yuan, with Xuerong contributing 10.2 million yuan (51%), Chenshi Biotechnology contributing 7 million yuan (35%), and Zheng Weidong contributing 2.8 million yuan (14%) [1] - The establishment of this subsidiary aligns with the company's strategy for diversified product offerings and aims to enhance production capacity utilization while reducing costs in the existing edible fungus business [1] Group 2 - Xuerong Biotechnology primarily engages in the research, industrial cultivation, and sales of fresh edible fungi [2] - In the first quarter of 2025, the company reported a revenue of 441 million yuan, a year-on-year decrease of 27.04%, while the net profit attributable to shareholders increased by 38.20% to 7.24 million yuan [2]